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Background: The study of the indications for cesarean section (CS) and its outcomes are useful for hospitals,
clinicians, and researchers in determining strategies to lower the primary and repeat CS rate. The aim of this study
was to identify the indications for CS and the incidence of adverse maternal/fetal outcomes in a tertiary care
setting.
Methods: A retrospective cohort study of women (n = 4305) who gave birth by CS at King Abdulaziz Medical City
(KAMC), Riyadh, Saudi Arabia (June 2008 to February 2011), was performed. All of the women’s medical records
were reviewed by two consulting physicians to obtain the primary indications for CS and determine the maternal
characteristics, type of CS (emergency or elective), and birth weight. All adverse maternal and fetal outcomes were
recorded. The point and interval estimates of the odds ratios were calculated using a logistic regression model to
identify the significant predictors of adverse maternal and/or fetal outcomes.
Results: Of a total of 22,595 deliveries from 2008 to 2011, 4,305 deliveries were CS deliveries (19.05%). Two-thirds
(67%) of all CS deliveries were emergency CSs, and the remaining deliveries were elective CSs (33%). Difficult labor
(35.9%), fetal distress (21.9%) and breech presentation (11.6%) were the most frequent indications of emergency CS,
while previous CS (54.3%), breech presentation (20.4%) and maternal request (10.1%) ranked first for elective CS.
Adverse maternal and fetal outcomes were diagnosed in 5.09% and 5.06% of deliveries, respectively, with a
significantly higher incidence in the emergency (6.06% & 5.51% respectively) than in elective CS (3.10 & 4.16%
respectively). Blood transfusion was the most frequent adverse maternal outcome (3.72%), followed by ICU
admission (0.63%), HELLP (0.51%), and hysterectomy (0.30%), while IUGR (3.25%) was the most frequent adverse fetal
outcome, followed by IUFD and the need for ICU admission (0.58% each). Adverse maternal outcomes were
significantly predicted by high gravidity (OR = 2.84, 95% CI:1.26-6.39, p = 0.011) and preeclampsia (OR = 2.84, 95%
CI:1.83-4.39, p < 0.001), while adverse fetal outcomes were predicted by: twinning (OR = 1.81, p = 0.002), hydramnios
(OR = 6.70, p < 0.001), and preeclampsia (OR = 2.74, p < 0.001). Preterm delivery was a significant predictor for both
adverse maternal and fetal outcomes (OR = 2.39, p < 0.001 & OR = 4.57, p < 0.001, respectively).
Conclusions: Difficult labor and previous CS were the main indications for CS in Saudi Arabia. High gravidity was
a significant predictor of adverse maternal outcomes. Encouraging Saudi women to consider embarking on
fewer pregnancies could act as a safeguard against mandatory CSs for subsequent births in multigravida and
grand-multigravida Saudi females. Future prospective study that addresses women with repeat CSs and their
association with adverse maternal and fetal outcomes is recommended.
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During the past several decades, cesarean section (CS)
has become a common operative procedure, with the
proportion of women giving birth by CS increasing
over time in all developed countries. In 2007, 30.9%
of Australian women gave birth by CS, which was
increased from 21% in 1998 [1]. In the USA, a similar
increase was reported, where 31.1% of all births were
delivered by CS in 2006, which was increased from
20.7% in 1996 [2]. In the UK, the overall rate of
cesarean birth is lower, accounting for nearly 25% of
all births from 2007 to 2008; however, this rate has
increased by approximately 50% from 1995–1996 [3].
In Europe, the rates vary considerably, with rates of
15% in Norway and The Netherlands, approximately 17%
in Sweden and Finland, and 37.8% in Italy [4]. In Saudi
Arabia, the CS rate (CSR) accounts for approximately 10%
of all births, reaching 20% in tertiary centers [5].
The observed increase in cesarean birth has been at-
tributed to a number of factors, including advanced ma-
ternal age, particularly with the first birth, multiple
pregnancies, breech presentation, suspected low infant
birth weight, private hospital status [6], and an increasing
maternal BMI [7]. Other factors include organizational
factors, the woman's choice regarding childbirth and
preferences for care, and the obstetrician's characteristics
and care practices [8].
CS constitutes a major surgical procedure and, as
such, is associated with a number of surgical complica-
tions. Despite this, a proportion of women are electing
to have their babies delivered in this manner without
any other indications [9]. It has been clearly proven that
an emergency CS is associated with a substantial morbid-
ity and mortality rates [10]. In the UK during 1994-1996,
maternal mortality was found to be 5.9 per 100,000
completed pregnancies for elective CS delivery versus 18.2
for emergency CS; maternal mortality for vaginal birth
was 2.1 per 100,000 completed pregnancies [11]. By
having an elective CS, any woman can make sure that she
does not run the medical and psychological risks of an
emergency CS, which have become more prominent
recently [11]. However, it has been reported that an
elective CS is less safer than a vaginal delivery, with
regard to maternal mortality [12,13].
High parity (5+) is common in developing countries,
particularly in Arab nations such Saudi Arabia, where
large families are the norm [14]. The association be-
tween multiparity and pregnancy outcomes has been
studied extensively [15-17]. Repeat CS is a common
phenomenon in the KSA, most likely due to cultural op-
position to CS limitation, as this would limit the size of
the family [18]. The CS will continue to increase due to
the strong wish to have large families in Saudi Arabia
and the self-perpetuating nature of CS. The aims of thisstudy were: 1) to identify the clinical indications for CS
deliveries in a tertiary hospital serving a high-parity
community, 2) to determine incidence of adverse mater-
nal and fetal outcomes in elective and emergency CS de-




This study was a retrospective cohort study consisting of
4,305 women who gave birth by CS.
Setting
King Abdulaziz Medical City (KAMC), Riyadh Saudi
Arabia, is a tertiary care hospital that serves a steady
population of the national guard, military personnel, and
civilians and their dependents. All deliveries are hospital
based and attended by midwives, and the information
was documented by the attending staff. The decision to
undertake CS was made by a specialist in every case.
The procedure itself was performed by specialists or by
residents under the specialist’s supervision. The hospital
stay duration was a minimum of 3 days. Therefore, the
data include all CS hospital deliveries.
Data collection
All medical records of the women who delivered by CS
between June 1, 2008, and February 2011 at KAMC were
reviewed by two consulting physicians to obtain the
primary indication for CS, and the following information
was extracted: maternal characteristics, such as maternal
age, parity (including the current delivery), previous
abortions, previous still births, number of live births, ges-
tational age (measured according to the last menstrual
period), birth weight, attendance for antenatal care, type
of delivery (emergency or elective CS), the number of pre-
vious CSs, indication for CS, and birth weight. All adverse
maternal and fetal outcomes were recorded. Adverse ma-
ternal outcomes included near miss or severe acute mater-
nal morbidity (near miss/SAMM) and maternal death.
Adverse fetal outcomes included intrauterine fetal death
(IUFD), neonatal death, the need for ICU admission,
IUGR, and intrauterine transfusion.
The indications were grouped hierarchically into the fol-
lowing 11 diagnostic categories for both elective and
emergency CS [19]: 1) difficult labor or dystocia, 2) fetal
distress, 3) previous CS, 4) breech presentation, including
frank breech, complete breech, or incomplete breech, with
either dystocia, fetal distress, none or both, or recognizing
that the breech presentation was a cause of both dystocia
and fetal distress, 5) delivery of a premature fetus, 6) ante-
partum hemorrhage (i.e., placental abruption or placenta
previa), 7) delivery of twins/triplets, 8) cord prolapse, 9)
maternal conditions (i.e., perineal repair, failed induction,
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verse lie, and fetal anomalies), and 11) maternal request.
Operational definitions
Planned operations - at a time that suited the woman and
the maternity team- were considered “elective”, whereas
all other operations were considered “emergency” [20].
The CSR is typically defined as the number of cesarean
deliveries over the total number of live births and is usu-
ally expressed as a percentage. However, in the present
study, only the proportion of CS deliveries as a percentage
of total deliveries was estimated. Parity was classified as
nulliparous (no previous viable pregnancy), multiparous
(given birth to 1–4 children), and grand-multiparous
(given birth to 5+ children) [21]. A stillborn baby was de-
fined as a baby born after the 24th week of pregnancy
who did not show any signs of life. If the baby died in the
womb, it was considered an intra-uterine stillbirth. If the
baby died during labor, it was considered an intra-partum
stillbirth. If the baby died before 24 weeks, it was consid-
ered a miscarriage. Fetal distress was determined by an
abnormal fetal heart rate pattern diagnosed either by aus-
cultation, continuous electronic fetal monitoring (EFM),
or signs of serious deficiency of the placenta, such as se-
vere intrauterine growth retardation. Dystocia was charac-
terized by the slow and abnormal progression of labor.
Because dystocia rarely can be diagnosed with certainty,
the imprecise term “failure to progress” has been used,
and this term includes the lack of progressive cervical dila-
tion, the lack of descent of the fetal head, or both [22].
HELLP syndrome is a serious complication in pregnancy
characterized by hemolysis, elevated liver enzymes, and
low platelet count. It is a recognized complication of pre-
eclampsia and eclampsia (toxemia) during pregnancy [23].
Women who experienced and survived a severe health
condition during pregnancy, childbirth or postpartum,
such as: hysterectomy, blood transfusion, ruptured uterus,
retained placenta, HELLP syndrome, pulmonary embol-
ism, renal failure, heart failure and pelvic abscess, are con-
sidered as near miss or severe acute maternal morbidity
(SAMM) cases [24,25].
Statistical analysis
Statistical analysis was conducted using SPSS (Statistical
Package for the Social Sciences) software. Descriptive
measures, such as the arithmetic mean and standard devi-
ation, were used to describe quantitative data. For quanti-
tative data, Student’s t-test was used to compare the
sample means. Pearson’s chi-square test was used to com-
pare categorical data. The point and interval estimates of
the odds ratios were calculated using a logistic regression
model including all the variables in the analysis. The
group with a lower risk of adverse maternal and/or fetal
outcomes was used as the reference category for eachvariable. All variables of known importance were included
in the model, even if they were not associated with adverse
outcome in an rx2 table, to control for their potential con-
founding effects. All variables were categorically repre-
sented, as the effects of the quantitative variables on the
outcome were unlikely to be linear or showed no linear
trends. Statistical significance was set at P < 0.05.
Ethical consideration
The study protocol was approved by the Institutional
Review Board of The Saudi Ministry of National Guard,
Health Affairs, Riyadh, Saudi Arabia. (Ref. #RR07/34).
Results
Of a total of 22,595 deliveries from 2008 to 2011, 4,305
deliveries were CS deliveries, with a rate of 19.05%. Of all
the CS deliveries, two-thirds (67%) were emergency CSs,
and one-third were elective CSs (33%). The women
ranged in age from 15 to 48 years, with a mean age of
30.86 ± 6.36 years. More than half (52.7%) of women were
of gravid 4 or more, with a mean gravidity of 4.60 ± 3.33.
Grand-multiparity (5+ births) was prevalent in 27.3% of
all women, with an average parity of 2.98 ± 88. The mean
gestational age was 37.97 ± 2.68 weeks, and the mean birth
weight was 3016.88 ± 667.27 grams. Women with elective
CSs showed a significantly higher mean age (32.77 ± 5.70
versus 29.88 ± 6.46 years, t = 15.01, p < 0.001), mean gra-
vidity, mean parity, and mean birth weight in grams,
whereas women with emergency CSs showed a signifi-
cantly higher gestational age in weeks.
More than one-third of the women (37.2%) had expe-
rienced one or more abortions and/or stillbirths; 5% gave
birth to twins. Additionally, 14.4% had one or more co-
morbidity; 18.8% of patients had GDM, 5.7% had ante-
partum hemorrhage, 4.9% had preeclampsia, and 5.5%
had hydramnios. Women who opted for elective CS
showed significantly higher rates of previous abortions
and/or still births, twinnings, and GDM, whereas women
who underwent emergency CS showed higher rates of
antepartum hemorrhage, preeclampsia, and hydramnios.
Moreover, a significantly higher proportion of the
women who underwent emergency CS did not receive
complete antenatal care (Table 1).
Indications for CS
Difficult labor and previous CSs (24% and 23.2%, respect-
ively) ranked first as indications for CS, followed by fetal
distress and breech presentation (14.7% and 14.5%, re-
spectively), maternal conditions (8%), APH (5.5%), mul-
tiple delivery (4.1%), and maternal request (3.3%); fetal
conditions and cord prolapse were indications in 1.3% and
1.2%, of the deliveries, respectively. Difficult labor (35.9%),
fetal distress (21.9%) and breech presentation (11.6%) were
the most frequent indications of emergency CS, while
Table 1 Demographic and obstetric characteristics of women who gave birth by cesarean section in central Saudi
Arabia
Characteristics Emergency (n = 2886, 67.0%) Elective (n = 1419, 33.0%) Total (n = 4305, 100.0%) Significant difference
No. % No. % No. %
Age group (years)
<20 96 3.3 12 0.8 108 2.5
20-24 559 19.4 107 7.5 666 15.5 χ2 = 204.82, p < 0.001**
25-29 794 27.5 290 20.4 1084 25.2
30+ 1437 49.8 1010 71.2 2447 56.8
Mean (SD) 29.94 ± 6.47 32.73 ± 5.72 30.86 ± 6.36 t = 14.38, p < 0.001**
Gravidity
One 744 25.8 105 7.4 849 19.7
Two 507 17.6 144 10.1 651 15.1 χ2 = 302.02, p < 0.001**
Three 340 11.8 198 14.0 538 12.5
Four or more 1295 44.9 972 68.5 2267 52.7
Mean (SD) 4.18 ± 3.34 5.47 ± 3.12 4.60 ± 3.33 t = 12.44,p < 0.001**
Parity
Nulliparity (0 births) 907 31.4 135 9.5 1042 24.2 χ2 = 253.73, p < 0.001**
Multiparity (1-4 births) 1295 44.9 794 56.0 2089 48.5
Grand multiparity(5+ births) 684 23.7 490 34.5 1174 27.3
Mean (SD) 2.59 ± 2.89 3.75 ± 2.70 2.98 ± 2.88 t = 12.92, p < 0.001**
Gestational age
<37 weeks (preterm) 610 21.1 172 12.1 782 18.2
37-42 weeks (term) 2156 74.7 1236 87.1 3392 78.8 χ2 = 96.90, p < 0.001**
>42 weeks (postterm) 120 4.2 11 0.8 131 3.0
Mean (SD) 38.07 ± 3.08 37.77 ± 1.56 37.97 ± 2.68 t = 4.17, p < 0.001**
Previous abortion/stillbirth 988 34.8 615 42.0 1603 37.2 χ2 = 21.86, p < 0.001**
Twinning 125 4.3 92 6.5 217 5.0 χ2 = 9.21,p = 0.002**
Birth weight (g)
<2500 (LBW) 560 19.4 156 11.0 716 16.6
2500-3500 (normal) 1638 56.8 1019 71.8 2657 61.7 χ2 = 94.79, p < 0.001**
>3500 (large) 688 23.8 244 17.2 932 21.6
Mean (SD) 2997.32 ± 730.89 3056.65 ± 512.09 3016.88 ± 667.27 t = 3.09, p = 0.002**
Antenatal care 2368 83.3 1378 94.2 3746 87.0 χ2 = 100.97, p < 0.001**
GDM 503 17.4 304 21.4 807 18.8 χ2 = 9.90, p = 0.002**
Maternal comorbidity 376 13.1 244 17.0 620 14.4 χ2 = 11.69, p = 0.001**
Antepartum hemorrhage 235 6.6 11 4.0 246 5.7 χ2 = 11.63, p = 0.001**
Preeclampsia 199 6.7 19 1.4 209 4.9 χ2 = 58.36, p < 0.001**
Hydramnios 172 6.1 63 4.2 235 5.5 χ2 = 6.40, p = 0.011**
χ2: Chi-square test, t: Student’s t-test, **: Statistically significant difference.
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ternal request (10.1%) were ranked first for elective CS.
(Figure 1).
Adverse obstetric outcomes of CS
Adverse maternal outcomes were diagnosed in 219
women, resulting in an incidence rate of 5.09 per 100 CSwomen. This rate was significantly higher among women
who underwent emergency CS (6.06%) than those who
underwent elective CS (3.10%) (χ2 = 17.30, p < 0.001).
Blood transfusion was the most frequent adverse mater-
nal outcome (3.72%), followed by ICU admission
(0.63%), HELLP (0.51%), and hysterectomy (0.30%). Add-
itionally, adverse fetal outcomes were diagnosed in 218
Figure 1 Indications for CS at King Abdulaziz Medical City,
Riyadh, Saudi Arabia. Note: Fetal conditions include macrosomia,
transverse lie and very premature fetus.
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rate was significantly higher among the emergency CSs
(5.51%) than the elective CSs (4.16%), (χ2 = 3.61, p = 0.029).
IUGR (3.25%) was the most frequent adverse fetal out-
come, followed by IUFD and the need for ICU admission
(0.58% each) (Table 2 & Figure 2).Table 2 Incidence of adverse maternal and fetal outcomes aft
City, Riyadh, Saudi Arabia
Obstetric outcomes Emergency (n = 2886) Elective (
No. % No.
Adverse fetal outcome@ 159 5.51 59
IUFD 22 2.9 3
IUGR 96 3.33 44
Neonatal death 5 0.17 3
ICU 23 0.80 2
Cong. anomaly 14 0.49 10
Adverse maternal outcome@ 175 6.06 44
ICU 23 0.80 4
Ruptured uterus 6 0.21 1
Hysterectomy 11 0.38 2
Blood transfusion 123 4.26 34
Retained placenta 4 0.14 0
HELLP syndrome 21 0.73 1
Pulmonary embolism 2 0.07 2
Renal failure 1 0.03 1
Heart failure 2 0.07 0
Bowel or bladder injury 10 0.35 2
Pelvic abscess 2 0.07 0
Maternal death 1 0.03 0
@: categories are not mutually exclusive.
χ2: Chi-square test, **: Statistically significant difference.Significant predictors of adverse maternal/fetal outcomes
Adverse maternal outcomes were significantly predicted in
CS by high gravidity, preeclampsia as well as prematurity.
Women giving birth to their fourth child were three times
(OR = 2.84, 95%CI:1.26-6.39, p = 0.011) more likely to ex-
perience adverse maternal outcomes compared to gravida
1 females. This was the same for preeclampsia (OR = 2.84,
95% CI:1.83-4.39, p < 0.001). Females with preterm delivery
were significantly more likely to suffer from abnormal
maternal outcomes than those females with term newborns
OR= 2.39, 95% CI:1.75-3.28, p < 0.001). (Table 3).
Adverse fetal outcomes were predicted in CSs by: twin-
ning, hydramnios, preeclampsia as well as prematurity.
Women giving birth to twin were two times (OR =
1.81,95% CI:1.25-2.61, p = 0.002) more likely to experience
adverse fetal outcomes compared to singleton women.
Pregnant women with hydramnios were sevenfold (OR =
6.70, 95% CI:4.57-9.83, p < 0.001) more likely to have ad-
verse fetal outcomes than those with normal amniotic fluid
levels. Women with preeclampsia were significantly three
times (OR = 2.74, 95% CI:1.75-4.30, p < 0.001) more likely
to have adverse fetal outcomes. Females with preterm de-
livery were significantly more likely to suffer from abnor-
mal fetal outcomes than those females with term newborns
(OR = 4.57, 95% CI: 3.33-6.28, p < 0.001). (Table 4).er emergency and elective CS at King Abdulaziz Medical
n = 1419) Total (n = 4305) Significant difference
% No. %



















Figure 2 Incidence of adverse maternal and fetal outcomes in
emergency and elective CS at King Abdulaziz Medical City,
Riyadh, Saudi Arabia.
Table 3 Predictors of adverse maternal outcomes for mothers
Saudi Arabia











Four or more 2267 140
Parity
Nulliparity (0 births) 1042 43
Multiparity (1-4 births) 2089 100
Grand multiparity(5+ births) 1174 76
Gestational age
37-42 weeks (term) 3392 134
<37 weeks (preterm) 782 80
>42 weeks (postterm) 131 5
Twinning 217 13
GDM 807 46
Maternal comorbidity 620 43
Preeclampsia 209 32
Hydramnios 235 14
**: Statistically significant difference, @—reference category, cOR–-crude odds ratio
Note: every variable was adjusted for all other variables in the table.
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CS is medically indicated when a significant risk of an
adverse outcome for the mother or fetus is present if the
operation is not performed at a given time. In contrast,
non-medically indicated CS occurs for reasons other
than a risk of adverse outcome [26]. At King Fahd
Armed Forces Hospital, which is a tertiary hospital in
Riyadh, Saudi Arabia, the CSR has always been below
15%; however, in 2007, the CSR exceeded 20%, a finding
that raised concern, as there was no change in the popu-
lation being served or in the type of practice [27]. In the
present study, CS deliveries constituted 19.05% of all de-
liveries between June 1, 2008, and February 2011 at
KAMC. International concern over such increases have
prompted the World Health Organization to suggest
that the CSR should not exceed 15% [28]; additionally,
some evidence has indicated that CSRs above 15% are
not associated with additional reductions in maternal or
neonatal mortality and morbidity [29].delivered by CS at King Abdulaziz Medical City, Riyadh,
utcome (n = 219, 5.09%) cOR (95%CI) aOR (95%CI)
% No.
2.8 1@ 1@




3.5 0.97 (0.56-1.67) 1.47(0.71-3.03)
4.6 1.29 (0.75-2.20) 2.17(0.95-4.96)
6.2 1.74 (1.17-2.58)** 2.84(1.26-6.39)**
4.1 1@ 1@
4.8 1.17(0.81-1.68) 0.60(0.30-1.18)
6.5 1.61 (1.09-2.36)** 0.65(0.31-1.37)
4.0 1@ 1@
10.2 2.77 (2.08-3.69)** 2.39(1.75-3.28)**
3.8 0.96(0.39-2.39) 1.10(0.44-2.75)
6.0 1.20 (0.67-2.14) 0.89(0.53-1.50)
5.7 1.16 (0.83-1.62) 1.05(0.74-1.49)
6.9 1.48 (1.05-2.09)** 1.14(0.80-1.64)
15.3 3.78 (2.52-5.66)** 2.84(1.83-4.39)**
6.0 1.19 (0.68-2.09) 1.11(0.63-1.95)
, aOR–-adjusted odds ratio.
Table 4 Predictors of adverse fetal outcomes for mothers delivered by CS at King Abdulaziz Medical City, Riyadh,
Saudi Arabia
Characteristics Total (n = 4305) Adverse fetal outcome (n = 218, 5.06%) cOR (95%CI) aOR (95%CI)
No. No. %
Maternal age (years)
<20 108 5 4.6 1@ 1@
20-24 666 50 7.5 1.68 (0.65-4.31) 1.39(0.51-3.76)
25-29 1084 62 5.7 1.26 (0.49-3.19) 1.23(0.45-3.34)
30+ 2447 101 4.1 0.89 (0.38-2.53) 0.86(0.31-2.40)
Gravidity
One 849 57 6.7 1@ 1@
Two 651 39 6.0 0.89 (0.58-1.35) 1.14(0.59-2.20)
Three 538 22 4.1 0.59(0.36-1.00) 0.94(0.42-2.08)
Four or more 2267 100 4.4 0.64 (0.46-0.90)** 1.35(0.62-2.90)
Parity
Nulliparity (0 births) 9.5 72 6.9 1@ 1@
Multiparity (1-4 births) 56.0 100 4.8 0.68 (0.50-0.93)** 0.71((0.37-1.36)
Grand multiparity(5+ births) 34.5 46 3.9 0.55(0.38-0.80)** 0.61(0.28-1.32)
Gestational age
37-42 weeks (term) 3392 98 2.9 1@ 1@
<37 weeks (preterm) 782 118 15.2 5.99 (4.52-7.92)** 4.57(3.33-6.28)**
>42 weeks (postterm) 131 2 1.5 0.52 (0.13-2.13) 0.51(0.12-2.12)
Twinning 217 36 16.6 1.25 (2.89-6.26)** 1.81(1.25-2.61)**
GDM 807 30 3.7 0.68 (0.46-1.01) 0.66(0.43-1.01)
Maternal comorbidity 620 34 5.5 1.12 (0.76-1.61) 0.98(0.65-1.47)
Preeclampsia 209 35 16.7 4.28(2.89-6.34)** 2.74(1.75-4.30)**
Hydramnios 235 49 21.1 6.16 (4.34-8.75)** 6.70(4.4.57-9.83)**
**: Statistically significant difference, @—reference category, cOR–-crude odds ratio, aOR–-adjusted odds ratio.
Note: every variable was adjusted for all other variables in the table.
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complex. Currently, in the developed world, approxi-
mately 30% of CSs are repeat CSs after a primary CS, 30%
are performed due to dystocia, 11% are performed due to
breech presentation, and 10% are performed due to fetal
distress [2,3]. The present study showed similar findings;
difficult labor and previous CS were the major indica-
tions for CS, followed by fetal distress, beech presenta-
tion, maternal condition, multiple delivery and maternal
request, whereas cord prolapse and fetal conditions were
the least common indications. The data demonstrated
that difficult labor, fetal distress, breech presentation and
APH were the main indications for emergency CS,
whereas previous CS, breech presentation, maternal re-
quest and maternal conditions were the main indications
for elective CS.
It has become clear that lower segment CS is less
likely associated with disastrous ruptures than in the
case of classical vertical scar, and the concept of ‘trial of
labor” became prevalent in subsequent deliveries. In thepresent study, more than half of the elective CSs (54.3%)
were prompted by a previous CS. This finding was simi-
lar to the results of other studies in Saudi Arabia [27,30].
The reluctance to permit a trial of labor after previous
CS is likely due to a variety of reasons. First, maternal
preference likely plays a large part, with CS being regarded
as a safe and convenient procedure. Second, the clinician
is also likely to regard the CS as a routine, safe, and
convenient alternative [31]. There is little work currently
available examining the reasons for the clinician's or
mother's choice in this area, particularly in communities
with high parity, such as the one included in this study, in
which more than a quarter (27.3%) of the patients were
grand multiparous, with five or more births.
There are well-documented adverse health outcomes
associated with cesarean birth, both for the woman and
her infant [32-40]. In the present study, adverse mater-
nal outcomes were diagnosed in 219 women, resulting
in an incidence rate of 5.09 per 100 CS women. It has
been clearly shown that an emergency CS is associated
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and the present study showed similar findings. Signifi-
cant maternal morbidity is often used as a proxy for ma-
ternal mortality, as maternal mortality rates, from any
cause, are low in developed countries [42]. In our study,
HELLP syndrome was identified in 5 out of 1000 CS
births and had a significantly higher incidence rate
among emergency CSs than elective CSs. This figure
was comparable with the 7.1 per 1000 CS births re-
ported by Zwart and colleagues [38]. However, HELLP
syndrome and preeclampsia may be conditions leading
to CS. Other adverse outcomes included the need for a
blood transfusion and ICU admission. In Bergholt's [32]
retrospective review of almost 1000 CSs, an estimated
blood loss of greater than 1000 ml was recorded in 9.2%
of the cesarean births, with 1% of women requiring a
blood transfusion. In our study, blood transfusion
ranked first as an adverse maternal outcome, with 3.72%
of women requiring a blood transfusion. According to the
administrative policy and procedure (APP#1427-04, 2013)
of the hospital for transfusion of blood and blood
components, Red Blood Cells may be transfused into
adult patients if any of the following criteria are met: Acute
blood loss due to obstetric hemorrhage characterized
by the loss of more than 15% of blood volume with
evidence of inadequate oxygen delivery; chronic symptom-
atic anemia of hemoglobin less than 80 g/L in patients with
operative procedures associated with major blood loss; or
as a preoperative preparation for Sickle Cell Disease
patients. Such APP may need to be revised to specify
the absolute and the easy to practise indications for blood
transfusion, in order to avoid the possible overuse of this
practice by health care providers.
In a large study of pregnancy outcomes in Latin
American countries conducted by the WHO, CS was as-
sociated with an increased risk of maternal death, al-
though the absolute risk of death was low (0.04% for
elective CS and 0.06% for emergency CS) [35]. In our
study, only one death was reported after emergency CS,
resulting in a rate of 0.03%. Gravidity, preeclampsia and
preterm delivery were identified as significant risk fac-
tors for adverse maternal outcomes. Gravida 4 females
were threefold more likely to experience adverse mater-
nal outcomes, when compared with gravida 1 females.
Pregnant women with preeclampsia were also threefold
more likely to suffer adverse maternal outcomes. With
preterm delivery, females were more than two times
more likely to suffer from adverse maternal outcomes
than with term delivery.
CS deliveries are associated with high risks of respira-
tory complications, neurological impairment of the new-
born, and long-term postpartum morbidity for the
mother [43]. Evidence suggests that term infants born by
elective CS under regional anesthesia have no greaterneed for resuscitation than those born vaginally [44-46].
In our study, only two infants were admitted to the ICU
(0.14%) following elective CS, whereas 0.80% of infants
born after emergency CS were admitted to the ICU.
However, these ICU admissions are more commonly
amongst preterm infants.
The association of CS with perinatal mortality remains
unclear. A reduction in the risk of perinatal deaths has
been cited as a potential benefit of cesarean birth [47].
In the present study, intrauterine fetal deaths (IUFD) oc-
curred at a rate of 5.8 per 1000 CS deliveries, and this
rate was significantly higher after emergency CS than
elective CS. Hopefully such deaths did not occur as a
consequence of the procedure, but they might be the
consequence of some confounders of emergency CS;
such as fetal disress which was the main indication for
21.9% of all emergency CSs. More than one-third of
women (37.2%) experienced one or more abortions
and/or stillbirths. Moreover, a total of 8 neonatal
deaths (1.9 per 1000 CS deliveries) were observed.
Adverse fetal outcomes after CS were predicted by pre-
term delivery, twinning, preeclampsia, and hydramnios.
Pregnant women with multiple pregnancy, preeclampsia
or hydramnios were two, three and sevenfold respectively,
more likely to have infants with adverse fetal outcomes
than those with no pregnancy risk. Females with preterm
delivery newborns were 4.6 times more likely to have
abnormal fetal outcomes than those females with term
newborns.
This was a large study conducted on a representative
population with a high participation rate, which identi-
fied the primary indications for CS among Saudi women
at a tertiary care facility. However, due to the retrospect-
ive nature of this study, the sensitivity and specificity of
the co-morbid diagnoses were variable, and the severity
and duration of these diseases were not properly fac-
tored into this analysis. Thus, there may be residual re-
lated to co-morbidity confounders in this study. No data
and therefore no analysis was available of women who
have undergone "many" previous Sections, especially in a
community of high parity. Moreover, the study was only
conducted in one setting and does not represent other
health care settings in Saudi Arabia. Thus, these findings
cannot be generalized.
Conclusions
Difficult labor and previous CS were the main indica-
tions for CS in Saudi Arabia, a country with high parity
and high gravidity. Blood transfusion was the most fre-
quent adverse maternal outcome, while IUGR was the
most frequent adverse fetal outcome. Gravidity was a
significant predictor of adverse maternal outcomes, and
Preterm delivery was a significant predictor of both ad-
verse maternal and fetal outcomes.
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encouraging women to consider embarking on fewer
pregnancies could act as a safeguard against mandatory
CSs for subsequent births in multigravida and grand-
multigravidi Saudi females, with further adverse maternal
and/or fetal outcomes. APP of transfusion of blood and
blood components may need to be revisited. Future pro-
spective study that addresses women with repeat CSs and
their association with adverse maternal and fetal outcomes
is recommended.
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